Clinical Trials Directory

Trials / Completed

CompletedNCT01928134

The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis

The Efficacy of Vitamin K2 on Human Osteoporosis, Blood-vessel Calcification and Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study used the generally recognized as safe (GRAS) grade of Bacillus subtilis natto to produce Vitamin K2, Menaquinone-7(MK-7), via fermentation, for functional evaluation. There are four major objectives for this study: (1) bioavailability of calcium; (2) evaluation of bone density improvement; (3) evaluation of blood-vessel calcification and sclerosis improvement; (4) safety evaluation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVit K2+ Vit D3+ calcium carbonate (CaCO3)
DIETARY_SUPPLEMENTVit K2+CaCO3

Timeline

Start date
2011-04-01
Primary completion
2011-11-01
Completion
2012-02-01
First posted
2013-08-23
Last updated
2013-08-23

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01928134. Inclusion in this directory is not an endorsement.

The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis (NCT01928134) · Clinical Trials Directory